Outro is a New York-based digital health company building an integrated deprescribing network that helps patients safely discontinue psychiatric medications, starting with antidepressants. Its Taper Management program pairs specially trained clinicians with evidence-informed hyperbolic tapering protocols, patient monitoring and psychosocial support, and is available in 14 US states. The company was co-founded by CEO Brandon Goode and Dr. Mark Horowitz, author of the Maudsley Deprescribing Guidelines.
1
Round
1
Industry
4
Tags
Oct 8, 2026
Latest raise
Funding activity · 1 round
Oct 8, 2026
$7M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
